The FDA approved Tybost (cobicistat) 150 mg tablets, a CYP3A inhibitor taken once daily with food to raise blood levels of atazanavir or darunavir in HIV-1 treatment. The most common reactions with atazanavir were jaundice, ocular icterus and nausea.
Section archive
Page 6 of 63
Drug
Prescription drugs, vaccines and their risks and benefits.
- All desks
- Abortion
- Accutane
- Acetaminophen
- Acid Reflux
- Acidic Foods
- Acne
- Acrylamide
- Acupuncture
- Additives
- ADHD
- Adiposity
- Advisories
- Aerobic Exercise
- Aflatoxin
- Agave
- Agent Orange
- Aging
- Agriculture
- AIDS
- Air Pollution
- Airline Passengers
- Airport
- ALA
- Alcohol
- Alcoholic Beverage
- Alerts
- Allergy
- Alli
- Aloe Vera
- ALS
- Alternative Medicine
- Aluminum
- Alzheimer's
- Amalgam
- AMD
- Ampyra
- Amygdala
- Anal Cancer
- And
- Anemia
- Angiogenesis
- Animal Protein
- Animals
- Anorexia
- Anthocyanins
- Anthrax
- Anti-Angiogenesis
- Anti-Obesity
- Antibacterial
- Antibiotic
Drug
HIV/AIDS Update - Approval of Vitekta
FDA approved Vitekta (elvitegravir) 85 mg and 150 mg tablets, an HIV-1 integrase strand transfer inhibitor taken once daily with food alongside a ritonavir-boosted protease inhibitor and another antiretroviral, for treatment-experienced adults.
Drug
FDA Updates for Health Professionals - 09.24.2014
An FDA Office of Health and Constituent Affairs roundup for September 24, 2014, listing recalls of Baxter potassium chloride injection over carton mislabeling, a Playtex electric breast pump over shock risk and Hospira heparin sodium over particulate matter, plus 32 labeling changes.
Drug
Antidiabetic drug may harm male fertility
A case report from the State University of Rio de Janeiro says liraglutide, prescribed for type 2 diabetes and obesity, had a harmful effect on male reproductive function, on top of known adverse effects such as acute pancreatitis and polyarthritis.
Drug
Are Your Sleeping Pills Causing "Night Eating"
The FDA has warned about Ambien hangovers, sedation and dangerous driving and recommended lower doses. Users report driving, eating, sexting and online shopping during Ambien blackouts, extending America's long attachment to sleeping pills back to the barbiturates of the 1960s.
Drug
Drug Information Update - FDA approves Trulicity to treat type 2 diabetes
FDA approved Trulicity (dulaglutide), a once-weekly injection to improve blood sugar control in adults with type 2 diabetes alongside diet and exercise. Six trials enrolled 3,342 patients. The drug carries a boxed warning over thyroid C-cell tumors seen in rodent studies.
Drug
Anxiety drugs linked to higher Alzheimer's disease risk
A case-control study using Quebec health insurance data found benzodiazepine use associated with a 51% higher risk of Alzheimer's disease five years later, 43% after adjusting for anxiety, depression and insomnia, with higher doses and longer-acting drugs linked to greater risk.
Drug
FDA approves weight-management drug Contrave
The FDA approved Contrave, extended-release naltrexone and bupropion, for chronic weight management alongside a reduced-calorie diet and exercise, in adults with a BMI of 30 or more, or 27 or more plus a condition such as hypertension, type 2 diabetes or high cholesterol.
Drug
Safe Medication Disposal Rules Change - News from St. Louis College of Pharmacy
New Justice Department and DEA rules taking effect next month will let participating pharmacies, some hospitals, clinics and long-term care facilities collect unwanted medications for disposal. Pharmacy professor Amy Tiemeier says leftover drugs at home invite theft.
Drug
FDA approves Keytruda for advanced melanoma - drug news
The FDA granted accelerated approval to Keytruda (pembrolizumab) for advanced or unresectable melanoma that no longer responds to other drugs. It is the first approved drug to block the PD-1 pathway and the sixth melanoma treatment cleared since 2011.
Drug
Med Watch: Dermatend Original and Dermatend Ultra: Recall - Safety Concerns
Solace International is recalling all lots and sizes of Dermatend Original and Dermatend Ultra, sold to remove moles, warts and skin tags, to the distributor and wholesaler level. FDA has not approved them, and using them instead of seeing a doctor could delay a cancer diagnosis.
Drug
Are the two FDA-approved weight loss drugs safe?
A JAMA Internal Medicine report urges caution with lorcaserin and phentermine/topiramate, which gave 3 and 7 percent more weight loss than placebo over a year but carry serious harms. European regulators rejected one; the other's maker withdrew its application.
Drug
Psoriasis Treatments Are Getting More Personalized
FDA dermatologist Melinda McCord says psoriasis care has moved on from the old step-by-step approach: doctors now try to match phototherapy or systemic therapy to each patient from the first visit. About 7.5 million Americans have the condition, and there is no cure.
Drug
Antidepressants, psychological therapies help irritable bowel syndrome
A review in the American Journal of Gastroenterology found antidepressants and psychological therapies were 33 percent more likely than placebo or usual care to improve irritable bowel syndrome symptoms, drawing on ten psychotherapy trials and four antidepressant trials.
Drug
Common antibiotic boosts heart death risk
Comparing 160,297 patients on clarithromycin with 4.3 million on penicillin V, researchers found ongoing clarithromycin use correlated with a 76% higher risk of cardiac death — about 37 deaths per million courses. The risk vanished after treatment stopped.
Drug
Hypnotics boost stroke and death risk
A case-control study of 2,779 stroke patients and 27,790 controls linked hypnotics such as zolpidem and estazolam to a 71% higher stroke risk. A separate study tied fewer than 18 hypnotic pills a year to a 260% higher death risk, and more than 132 pills to 430%.
Drug
FDA Okays Avastin to treat aggressive and late-stage cervical cancer
The FDA cleared Avastin, combined with paclitaxel and either cisplatin or topotecan, for persistent, recurrent or metastatic cervical cancer. Officials call it the first drug approved for late-stage cervical cancer since topotecan with cisplatin in 2006.
Drug
FDA approves Avastin to treat patients with aggressive and late-stage cervical cancer
FDA approved Avastin (bevacizumab) for persistent, recurrent or metastatic cervical cancer, given with paclitaxel plus cisplatin or paclitaxel plus topotecan. Officials call it the first drug cleared for late-stage cervical cancer since 2006, approved in under four months on priority review.
1120 stories